Patents by Inventor Christopher KEMBALL

Christopher KEMBALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUNDS, AND METHODS OF USE THEREOF
    Publication number: 20230071763
    Abstract: The invention relates generally to novel compounds of the auristatin family, to novel linkers for coupling a payload to another molecule, such a target-binding molecule, to novel linker-toxin molecules, and to novel antibody molecules that allow controlled, site-specific conjugation.
    Type: Application
    Filed: January 6, 2021
    Publication date: March 9, 2023
    Inventors: Siew Schleyer, Brian A. Mendelsohn, Pia Challita-Eid, Dowdy Jackson, Christopher Kemball
  • ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF
    Publication number: 20230073692
    Abstract: The invention relates generally to antibodies that bind SLC34A2, and methods of making and using these anti-SLC34A2 antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
    Type: Application
    Filed: January 6, 2021
    Publication date: March 9, 2023
    Inventors: Dowdy Jackson, Yuriy Shostak, Christopher Kemball, Pia Challita-Eid
  • SINGLE-AND MULTI-CHAIN POLYPEPTIDES THAT BIND SPECIFICALLY TO CD3 EPSILON
    Publication number: 20230057263
    Abstract: Provided herein are single-chain polypeptides and multi-chain polypeptides that bind specifically to CD3 epsilon (CD3?). Also provided herein are anti-idiotypic antibodies that bind specifically to any of the antigen-binding domains described herein.
    Type: Application
    Filed: January 6, 2021
    Publication date: February 23, 2023
    Applicant: CYTOMX THERAPEUTICS, INC.
    Inventors: Christopher KEMBALL, Pia CHALLITA-EID, Rene HUBERT
  • ANTI-PSMA ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF
    Publication number: 20230059690
    Abstract: The invention relates generally to antibodies that bind PSMA, and methods of making and using these anti-PSMA antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
    Type: Application
    Filed: January 6, 2021
    Publication date: February 23, 2023
    Inventors: Rene Hubert, Christopher Kemball, Pia Challita-Eid